AVS Bio
Carlo S. is an accomplished executive with extensive experience in corporate development and mergers and acquisitions within the life sciences sector. Currently serving as the VP of Corporate Development at AVS Bio since April 2025, Carlo S. previously held the position of Head of Corporate M&A at Alira Health from September 2014 to April 2025, where over 10 successful transactions were executed to enhance the company’s services and technologies. Carlo S. has also led the Global Transaction Advisory practice at Alira Health, focusing on innovative deal structures in medical devices and life sciences services. Additional experience includes managing early-stage investments at Alira Health Ventures and providing M&A advisory services at Buttignon Zotti Milan & Co. Carlo S. holds an MBA from IE Business School and a Master's in Business & Finance from the Università degli Studi di Verona.
This person is not in any teams
This person is not in any offices
AVS Bio
1 followers
AVS Bio is a global leader in providing Specific Pathogen Free (SPF) eggs, laboratory products, and testing services to the biologics industry. Our world-class products and services are trusted by customers in both human and animal health markets. Our commitment to quality, biosecurity, and scientific innovation has set the standard for our industry for over five decades. We are dedicated to relentlessly improving and expanding our offerings to meet the evolving needs of our dynamic customer base. At AVS Bio, we value our employees and are actively hiring for positions in New York, Connecticut, Illinois, and Missouri. We post new job opportunities regularly here. If you are passionate about contributing to a team that is significantly impacting the biologics industry, we encourage you to apply.